The facility, spread over 41,600 ft² of the research institute, has a capacity to store stem cells of 20,000 patients.
Under the partnership with Yanda Group, RNL will take up the charge of stem cell storage in the GMP facility and management of medical treatment.
The clinical research and treatment of patients by stem cell therapy will be administered by Yanda Group.
RNL Stem Cell Institute president Jeong Chan Ra said through the stem cell treatment in China, the company hopes to offer broader opportunities to patients with incurable diseases.